Ampio Pharmaceuticals, Inc. (AMPE)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 02:48PM EDT
Ampio Pharmaceuticals, Inc.
9800 Mount Pyramid Court
Suite 400
Englewood, CO 80112
United States
720 437 6500
https://ampiopharma.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 6
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Michael A. Martino | CEO, CFO, General Secretary & Director | 550k | N/A | 1957 |
| Dr. David Bar-Or M.D. | Founder & Chairman of Scientific Advisory Board | 145.6k | N/A | 1949 |
| April Ramirez | Clinical Trial Manager | N/A | N/A | N/A |
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Corporate Governance
Ampio Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
© 2024 Yahoo. All rights reserved.